Visit of the Singapore Immunology Network (SIgN)

SIgN was established in 2006 by the Agency for Science, Technology and Research (A*STAR) with the aim of expanding and strengthening immunology research in Singapore by making innovative discoveries to improve lives and further socio-economic growth.

SIgN was established in 2006 by the Agency for Science, Technology and Research (A*STAR) with the aim of expanding and strengthening immunology research in Singapore by making innovative discoveries to improve lives and further socio-economic growth.

SIgN is committed to translate research findings into clinical and commercial applications, in partnership with clinics and industry.

The visit will start with a seminar to introduce SIgN’s activities and researches leaded in the institute. Participants will then be invited to visit the technological platforms and one of its research lab working on dengue.

About the speaker

• Laurent Renia, Executive Director of the Singapore Immunology Network (SIgN)

Laurent Renia obtained his PhD in 1991 from Universite Pierre et Marie Curie in Paris, France where he studied the immune response against the pre-erythrocytic phase of malaria. He continued to work on malaria immunology in New York University (1991-1992). He then returned to Paris in 1993 where he obtained a permanent position as junior research scientist at the French National Institute of Health (INSERM) working on malaria immunology in the INSERM Unit 313 at the Hopital Pitie-Salpetriere in Paris.

He moved to the INSERM Unit 445 at the Institut Cochin in Paris where he started his own group in 1997. Between 2001-2006, he became research director at INSERM, co-director and director of the Department of Immunology at the Institut Cochin.  He joined SIgN in 2007. He holds adjunct Professorships with the Department of Microbiology, Yong Loo Lin School of Medicine at the National University of Singapore, at the School of biological Sciences, Nanyang technological University in Singapore, and to the French National Institute of Health (INSERM).

He has published more than 250 articles and book chapters. He is an Academic Editor for Infection and Immunity, PLoS ONE, Infection and Immunity, Microbial Pathogenesis, Microbial cell  and Frontiers in Immunology.

Terms and conditions

• This event is for members and FrenchLab members only.
• Please note that photographs and videos may be taken during the event for news and publicity purposes.

Modalités d'accès